Clinical Trial Update: A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis. [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamics of AZD5492 in adults with systemic lupus erythematosus, idiopathic i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Inflammatory Myopathies
• Rheumatoid Arthritis
• Systemic Lupus Erythematosus

Drugs mentioned

• AZD5492 (AZD5492)

Snippet

Sponsor: AstraZeneca | Conditions: Systemic Lupus Erythematosus, Idiopathic Inflammatory Myopathies | Phase 1 | Status: RECRUITING